未登录 Integrated Safety Update of Abrocitinib in 3802 Patients with Moderate-to-Severe Atopic Dermatitis: Data from More than 5200 Patient-Years with Up to 4 Years of Exposure Simpson, Eric L.; Silverberg, Jonathan I.; Nosbaum, Audrey; Winthrop, Kevin; Guttman-Yassky, Emma; Hoffmeister, Karin M.; Egeberg, Alexander; Valdez, Hernan; Fan, Haiyun; Farooqui, Saleem A.; Chan, Gary; Alderfer, Justine; Romero, William; Chittuluru, Kanti 分享 收藏
Optimizing maintenance therapy in responders to abrocitinib induction: A post hoc analysis of JADE REGIMEN Thyssen, J. P.; Silverberg, J. I.; Ruano, J.; Blauvelt, A.; Gubelin, W.; Simpson, E. L.; Weidinger, S.; Valdez, H.; Terry, K. K.; Biswas, P.; Guler, E.; Feeney, C. 分享 收藏
Interpreting the Relationship Among Itch, Sleep, and Work Productivity in Patients with Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of JADE MONO-2 Yosipovitch, Gil; Gooderham, Melinda J.; Staender, Sonja; Fonacier, Luz; Szepietowski, Jacek C.; Deleuran, Mette; Girolomoni, Giampiero; Su, John C.; Bushmakin, Andrew G.; Cappelleri, Joseph C.; Feeney, Claire; Chan, Gary; Thorpe, Andrew J.; Valdez, Hernan; Biswas, Pinaki; Rojo, Ricardo; Dibonaventura, Marco; Myers, Daniela E. 分享 收藏
Safety of abrocitinib in 3582 patients with moderate-to-severe atopic dermatitis with over 900 patients exposed for almost 2 years Simpson, Eric L.; Silverberg, Jonathan, I; Nosbaum, Audrey; Winthrop, Kevin; Guttman-Yassky, Emma; Hoffmeister, Karin M.; Egeberg, Alexander; Valdez, Hernan; Fan, Haiyun; Farooqui, Saleem A.; Chan, Gary; Alderfer, Justine; Romero, William; Johnson, Susan 分享 收藏
Early Itch Response with Abrocitinib Is Associated with Later Efficacy Outcomes in Patients with Moderate-to-Severe Atopic Dermatitis: Subgroup Analysis of the Randomized Phase III JADE COMPARE Trial Staender, Sonja; Kwatra, Shawn G.; Silverberg, Jonathan, I; Simpson, Eric L.; Thyssen, Jacob P.; Yosipovitch, Gil; Zhang, Fan; Cameron, Michael C.; Cella, Ricardo Rojo; Valdez, Hernan; DiBonaventura, Marco; Feeney, Claire 分享 收藏
Magnitude and Time Course of Response to Abrocitinib for Moderate-to-Severe Atopic Dermatitis Reich, Kristian; Lio, Peter A.; Bissonnette, Robert; Alexis, Andrew F.; Lebwohl, Mark G.; Pink, Andrew E.; Kabashima, Kenji; Boguniewicz, Mark; Nowicki, Roman J.; Valdez, Hernan; Zhang, Fan; DiBonaventura, Marco; Cameron, Michael C.; Clibborn, Claire 分享 收藏
Patient perspectives of atopic dermatitis: comparative analysis of terminology in social media and scientific literature, identified by a systematic literature review Silverberg, J., I; Feldman, S. R.; Begolka, W. Smith; Johnson, M. B.; Stanojev, C.; DiBonaventura, M.; Cella, R. Rojo; Valdez, H.; Feeney, C.; Thyssen, J. P. 分享 收藏
Durability of Response to Abrocitinib in Patients with Moderate-to-Severe Atopic Dermatitis After Treatment Discontinuation in a Phase 2b Trial Gooderham, Melinda J.; Girolomoni, Giampiero; Moore, Julian O.; Silverberg, Jonathan, I; Bissonnette, Robert; Forman, Seth; Peeva, Elena; Biswas, Pinaki; Valdez, Hernan; Chan, Gary 分享 收藏
Phase 3 efficacy and safety of abrocitinib in adults with moderate-to-severe atopic dermatitis after switching from dupilumab (JADE EXTEND) Shi, Vivian Y.; Bhutani, Tina; Fonacier, Luz; Deleuran, Mette; Shumack, Stephen; Valdez, Hernan; Zhang, Fan; Chan, Gary L.; Cameron, Michael C.; Yin, Natalie C. 分享 收藏
分享 收藏
Rapidity of Improvement in Signs/Symptoms of Moderate-to-Severe Atopic Dermatitis by Body Region with Abrocitinib in the Phase 3 JADE COMPARE Study Alexis, Andrew; de Bruin-Weller, Marjolein; Weidinger, Stephan; Soong, Weily; Barbarot, Sebastien; Ionita, Ileana; Zhang, Fan; Valdez, Hernan; Clibborn, Claire; Yin, Natalie 分享 收藏
Abrocitinib induction, randomized withdrawal, and retreatment in patients with moderate-to-severe atopic dermatitis: Results from the JAK1 Atopic Dermatitis Efficacy and Safety (JADE) REGIMEN phase 3 trial Blauvelt, Andrew; Silverberg, Jonathan, I; Lynde, Charles W.; Bieber, Thomas; Eisman, Samantha; Zdybski, Jacek; Gubelin, Walter; Simpson, Eric L.; Valenzuela, Fernando; Criado, Paulo Ricardo; Lebwohl, Mark G.; Feeney, Claire; Khan, Tahira; Biswas, Pinaki; DiBonaventura, Marco; Valdez, Hernan; Cameron, Michael C.; Rojo, Ricardo 分享 收藏
Patient-reported outcomes from the JADE COMPARE randomized phase 3 study of abrocitinib in adults with moderate-to-severe atopic dermatitis Thyssen, J. P.; Yosipovitch, G.; Paul, C.; Kwatra, S. G.; Chu, C. Y.; DiBonaventura, M.; Feeney, C.; Zhang, F.; Myers, D.; Rojo, R.; Valdez, H. 分享 收藏
Impact of oral abrocitinib on signs, symptoms and quality of life among adolescents with moderate-to-severe atopic dermatitis: an analysis of patient-reported outcomes Cork, M. J.; McMichael, A.; Teng, J.; Valdez, H.; Rojo, R.; Chan, G.; Zhang, F.; Myers, D. E.; DiBonaventura, M. 分享 收藏
Integrated Safety Analysis of Abrocitinib for the Treatment of Moderate-to-Severe Atopic Dermatitis From the Phase II and Phase III Clinical Trial Program (vol 22, pg 693, 2021) Simpson, Eric L.; Silverberg, Jonathan I.; Nosbaum, Audrey; Winthrop, Kevin L.; Guttman-Yassky, Emma; Hoffmeister, Karin M.; Egeberg, Alexander; Valdez, Hernan; Zhang, Min; Farooqui, Saleem A.; Romero, William; Thorpe, Andrew J.; Rojo, Ricardo; Johnson, Susan 分享 收藏
Efficacy and Safety of Abrocitinib in Combination With Topical Therapy in Adolescents With Moderate-to-Severe Atopic Dermatitis The JADE TEEN Randomized Clinical Trial Eichenfield, Lawrence F.; Flohr, Carsten; Sidbury, Robert; Siegfried, Elaine; Szalai, Zsuzsanna; Galus, Ryszard; Yao, Zhirong; Takahashi, Hidetoshi; Barbarot, Sebastien; Feeney, Claire; Zhang, Fan; DiBonaventura, Marco; Rojo, Ricardo; Valdez, Hernan; Chan, Gary 分享 收藏
Impact of Oral Abrocitinib Monotherapy on Patient-Reported Symptoms and Quality of Life in Adolescents and Adults with Moderate-to-Severe Atopic Dermatitis: A Pooled Analysis of Patient-Reported Outcomes (vol 22, pg 541, 2021) Silverberg, Jonathan I.; Thyssen, Jacob P.; Simpson, Eric L.; Yosipovitch, Gil; Stander, Sonja; Valdez, Hernan; Rojo, Ricardo; Biswas, Pinaki; Myers, Daniela E.; Feeney, Claire; DiBonaventura, Marco 分享 收藏
Integrated Safety Analysis of Abrocitinib for the Treatment of Moderate-to-Severe Atopic Dermatitis From the Phase II and Phase III Clinical Trial Program Simpson, Eric L.; Silverberg, Jonathan I.; Nosbaum, Audrey; Winthrop, Kevin L.; Guttman-Yassky, Emma; Hoffmeister, Karin M.; Egeberg, Alexander; Valdez, Hernan; Zhang, Min; Farooqui, Saleem A.; Romero, William; Thorpe, Andrew J.; Rojo, Ricardo; Johnson, Susan 分享 收藏
Rapid Improvement of Itch Associated With Atopic Dermatitis With Abrocitinib Is Partially Independent of Overall Disease Improvement: Results From Pooled Phase 2b and 3 Monotherapy Studies Kim, Brian S.; Silverberg, Jonathan, I; Stander, Sonja; Yosipovitch, Gil; Simpson, Eric L.; DiBonaventura, Marco; Kerkmann, Urs; Farooqui, Saleem A.; Biswas, Pinaki; Valdez, Hernan; Cameron, Michael C. 分享 收藏
Contribution of a European-Prevalent Variant near CD83 and an East Asian-Prevalent Variant near IL17RB to Herpes Zoster Risk in Tofacitinib Treatment: Results of Genome-Wide Association Study Meta-Analyses Bing, Nan; Zhou, Huanyu; Chen, Xing; Hirose, Tomohiro; Kochi, Yuta; Tsuchida, Yumi; Ishigaki, Kazuyoshi; Sumitomo, Shuji; Fujio, Keishi; Zhang, Baohong; Valdez, Hernan; Vincent, Michael S.; Martin, David; Clark, James D. 分享 收藏
.png){kind=icon}
未登录.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
